# Drug-Drug Interaction Study: ASP2151 and Midazolam

> **NCT02403635** · PHASE1 · COMPLETED · sponsor: **Maruho Europe Limited** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Midazolam
- **DRUG:** ASP2151

## Key facts

- **NCT ID:** NCT02403635
- **Lead sponsor:** Maruho Europe Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02403635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02403635, "Drug-Drug Interaction Study: ASP2151 and Midazolam". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02403635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*